NASDAQ:EARS
Delisted

Auris Medical Holding AG Stock Price (Quote)

$0.750
-0.0010 (-0.133%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.680 $1.00 Friday, 27th May 2022 EARS stock ended at $0.750. This is 0.133% less than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 10.68% from a day low at $0.740 to a day high of $0.82.
90 days $0.635 $2.14
52 weeks $0.635 $4.58

Historical Auris Medical Holding AG prices

Date Open High Low Close Volume
Apr 27, 2021 $3.38 $3.47 $3.32 $3.43 431 284
Apr 26, 2021 $3.42 $3.42 $3.22 $3.41 642 721
Apr 23, 2021 $3.08 $3.38 $3.01 $3.34 1 095 743
Apr 22, 2021 $3.00 $3.18 $2.90 $3.08 990 484
Apr 21, 2021 $2.99 $3.08 $2.90 $2.99 1 081 989
Apr 20, 2021 $3.37 $3.43 $2.76 $2.80 2 837 499
Apr 19, 2021 $3.48 $3.52 $3.32 $3.43 694 752
Apr 16, 2021 $3.55 $3.59 $3.32 $3.50 935 343
Apr 15, 2021 $3.77 $3.80 $3.51 $3.52 1 039 464
Apr 14, 2021 $4.00 $4.14 $3.70 $3.73 2 242 719
Apr 13, 2021 $4.08 $4.49 $3.77 $4.30 9 121 574
Apr 12, 2021 $5.28 $5.45 $4.16 $4.30 55 464 854
Apr 09, 2021 $3.81 $4.36 $3.76 $4.31 8 740 835
Apr 08, 2021 $3.36 $4.38 $3.34 $3.89 49 396 988
Apr 07, 2021 $3.30 $3.40 $3.15 $3.22 453 929
Apr 06, 2021 $3.12 $3.53 $3.08 $3.32 5 358 866
Apr 05, 2021 $3.21 $3.25 $3.01 $3.09 1 125 011
Apr 01, 2021 $3.59 $3.63 $3.31 $3.42 589 877
Mar 31, 2021 $3.23 $3.49 $3.23 $3.48 660 833
Mar 30, 2021 $3.13 $3.44 $2.96 $3.23 641 020
Mar 29, 2021 $3.40 $3.44 $3.10 $3.11 608 510
Mar 26, 2021 $3.54 $3.58 $3.30 $3.38 459 577
Mar 25, 2021 $3.30 $3.50 $3.25 $3.41 768 523
Mar 24, 2021 $3.66 $3.82 $3.44 $3.48 507 057
Mar 23, 2021 $3.92 $4.03 $3.56 $3.62 725 497
Click to get the best stock tips daily for free!

About Auris Medical Holding AG

Auris Medical Holding AG Auris Medical Holding AG, a clinical-stage biopharmaceutical company, focuses on the development of novel products for the treatment of inner ear disorders. Its lead product candidate includes AM-101, which is in Phase III clinical development for treating acute inner ear tinnitus. The company is also developing AM-111 for the treatment of acute sensorineural hearing loss; and other pre-clinical stage products comprising AM-102 and AM-123. It has... EARS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT